Pfizer acquires Metsera for $4.9 billion, enhancing its portfolio in obesity and cardiovascular treatments with innovative ...
Peter Rubin discusses how the industry is an ecosystem and each of the parts will feel the impact differently.
Rob DeWig, VP of Healthcare Sales at Inmar, touches on how access to 25% of benchmarking data from national pharmacy claims ...
Ryan Quigley, CEO of Inizio, explains how AI, personalized medicine, and GLP 1s are shaping commercialization trends.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback